Brensocatib Receives FDA Approval: Key Findings on Safety and Efficacy
The recent FDA approval of brensocatib, marketed as Brinsupri, marks a significant advancement in the treatment of bronchiectasis. This medication, which received approval in August 2025, is the focus of…